Target intelligence / Profile preview

Festuca pratensis pollen allergen (Fes p) (Fes p)

Target
Fes p
Molecular classification
Other
01

Overview

Festuca pratensis pollen allergen refers to a group of proteins found in the pollen of Meadow Fescue, a common perennial grass in the Poaceae family. These allergens, such as Fes p 1 and Fes p 5, are potent triggers of Type I hypersensitivity reactions in sensitized individuals (WHO/IUIS Allergen Nomenclature, 2024). Upon inhalation, these proteins cross-link allergen-specific IgE antibodies bound to mast cells and basophils, leading to the degranulation and release of inflammatory mediators like histamine (UniProt, P43177). This process results in clinical manifestations such as allergic rhinitis, conjunctivitis, and bronchial asthma (World Allergy Organization, 2023). In the context of clinical pharmacology, these allergens are the primary active ingredients in allergen-specific immunotherapy (AIT) products. AIT aims to modify the disease course by inducing peripheral immune tolerance, which involves the expansion of regulatory T cells and the production of IgG4 blocking antibodies that prevent IgE-mediated allergic cascades (PubMed, PMID: 31034515). This therapeutic approach shifts the immune response from a Th2-dominated profile to a Th1-dominated profile, providing long-term relief from symptoms (Journal of Allergy and Clinical Immunology, 2020). Safety concerns during treatment include the risk of local or systemic allergic reactions, including rare instances of anaphylaxis.

Other names
Meadow fescue pollen allergenFes p allergensFes p 1Fes p 2Fes p 3Fes p 4Fes p 5Fes p 13
02

Mechanism of action

Induction of immune tolerance by shifting the immune response from Th2 to Th1, increasing regulatory T cell (Treg) activity, and stimulating the production of allergen-specific IgG4 blocking antibodies.

03

Biological functions

Immune responseOther
04

Disease associations

InflammationOther
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal site reactions (e.g., oral itching, swelling)Eosinophilic esophagitis
06

Interacting drugs

Grass pollen extract

2 more in the full profile.

07

Biomarkers

Specific IgE (sIgE)Specific IgG4 (sIgG4)Skin prick test (SPT) reactivityBasophil activation test (BAT)

Beyond the preview

Go deeper on Festuca pratensis pollen allergen (Fes p) (Fes p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Festuca pratensis pollen allergen (Fes p) (Fes p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call